+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Specialty Drug Distribution Market Research Report by Distribution Type, by Indication, by Distribution Channel, by State - United States Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 5124497
  • Report
  • September 2021
  • Region: United States
  • 85 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The United States Specialty Drug Distribution Market Will Grow to USD 654.00 Million by 2026, at a CAGR of 13.84%

FEATURED COMPANIES

  • Anda, Inc.
  • Avella Specialty Pharmacy
  • Biologics, Inc.
  • CuraScript, Inc.
  • CVS Health Corporation
  • Diplomat Pharmacy, Inc.
  • MORE
The United States Specialty Drug Distribution Market size was estimated at USD 300.42 Million in 2020 and expected to reach USD 340.41 Million in 2021, at a Compound Annual Growth Rate (CAGR) 13.84% to reach USD 654.00 Million by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Specialty Drug Distribution to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Distribution Type, the Specialty Drug Distribution Market was studied across Clinic/ASCs, Home Health, Inpatient, Mail Delivery, Outpatient, and Retail.
  • Based on Type, the Specialty Drug Distribution Market was studied across Full line Wholesalers and Specialty Distributors.
  • Based on Indication, the Specialty Drug Distribution Market was studied across AIDS, Hemophilia, Multiple Sclerosis, Oncology, and Rheumatoid Arthritis.
  • Based on Distribution Channel, the Specialty Drug Distribution Market was studied across Hospitals & Care Providers, Independent Pharmacies, Large Chain Pharmacies, Online Stores, and Specialty Pharmacies.
  • Based on State, the Specialty Drug Distribution Market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Specialty Drug Distribution Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Specialty Drug Distribution Market, including Anda, Inc., Avella Specialty Pharmacy, Biologics, Inc., CuraScript, Inc., CVS Health Corporation, Diplomat Pharmacy, Inc., Express Scripts Holding Company, Greenhill & Co., Inc., and Pfizer Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States Specialty Drug Distribution Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Specialty Drug Distribution Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Specialty Drug Distribution Market?
4. What is the competitive strategic window for opportunities in the United States Specialty Drug Distribution Market?
5. What are the technology trends and regulatory frameworks in the United States Specialty Drug Distribution Market?
6. What is the market share of the leading vendors in the United States Specialty Drug Distribution Market?
7. What modes and strategic moves are considered suitable for entering the United States Specialty Drug Distribution Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Anda, Inc.
  • Avella Specialty Pharmacy
  • Biologics, Inc.
  • CuraScript, Inc.
  • CVS Health Corporation
  • Diplomat Pharmacy, Inc.
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Distribution Type Outlook
3.4. Type Outlook
3.5. Indication Outlook
3.6. Distribution Channel Outlook
3.7. State Outlook
3.8. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges

6. Specialty Drug Distribution Market, by Distribution Type
6.1. Introduction
6.2. Clinic/ASCs
6.3. Home Health
6.4. Inpatient
6.5. Mail Delivery
6.6. Outpatient
6.7. Retail

7. Specialty Drug Distribution Market, by Type
7.1. Introduction
7.2. Full line Wholesalers
7.3. Specialty Distributors

8. Specialty Drug Distribution Market, by Indication
8.1. Introduction
8.2. AIDS
8.3. Hemophilia
8.4. Multiple Sclerosis
8.5. Oncology
8.6. Rheumatoid Arthritis

9. Specialty Drug Distribution Market, by Distribution Channel
9.1. Introduction
9.2. Hospitals & Care Providers
9.3. Independent Pharmacies
9.4. Large Chain Pharmacies
9.5. Online Stores
9.6. Specialty Pharmacies

10. California Specialty Drug Distribution Market
10.1. Introduction

11. Florida Specialty Drug Distribution Market
11.1. Introduction

12. Illinois Specialty Drug Distribution Market
12.1. Introduction

13. New York Specialty Drug Distribution Market
13.1. Introduction

14. Ohio Specialty Drug Distribution Market
14.1. Introduction

15. Pennsylvania Specialty Drug Distribution Market
15.1. Introduction

16. Texas Specialty Drug Distribution Market
16.1. Introduction

17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis
17.3. Market Share Analysis, By Key Player
17.4. Competitive Scenario
17.4.1. Merger & Acquisition
17.4.2. Agreement, Collaboration, & Partnership
17.4.3. New Product Launch & Enhancement
17.4.4. Investment & Funding
17.4.5. Award, Recognition, & Expansion

18. Company Usability Profiles
18.1. Anda, Inc.
18.2. Avella Specialty Pharmacy
18.3. Biologics, Inc.
18.4. CuraScript, Inc.
18.5. CVS Health Corporation
18.6. Diplomat Pharmacy, Inc.
18.7. Express Scripts Holding Company
18.8. Greenhill & Co., Inc.
18.9. Pfizer Inc.

19. Appendix
19.1. Discussion Guide
19.2. License & Pricing

List of Figures
FIGURE 1. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2020 (USD MILLION)
FIGURE 3. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 4. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2020 (USD MILLION)
FIGURE 5. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 (USD MILLION)
FIGURE 6. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 7. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 8. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET: MARKET DYNAMICS
FIGURE 9. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2020 VS 2026 (%)
FIGURE 10. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2026
FIGURE 12. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY CLINIC/ASCS, 2018-2026 (USD MILLION)
FIGURE 13. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY CLINIC/ASCS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 14. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME HEALTH, 2018-2026 (USD MILLION)
FIGURE 15. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME HEALTH, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 16. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INPATIENT, 2018-2026 (USD MILLION)
FIGURE 17. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INPATIENT, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 18. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MAIL DELIVERY, 2018-2026 (USD MILLION)
FIGURE 19. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MAIL DELIVERY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 20. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY OUTPATIENT, 2018-2026 (USD MILLION)
FIGURE 21. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY OUTPATIENT, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 22. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RETAIL, 2018-2026 (USD MILLION)
FIGURE 23. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RETAIL, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 24. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
FIGURE 25. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2026
FIGURE 27. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY FULL LINE WHOLESALERS, 2018-2026 (USD MILLION)
FIGURE 28. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY FULL LINE WHOLESALERS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 29. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY DISTRIBUTORS, 2018-2026 (USD MILLION)
FIGURE 30. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY DISTRIBUTORS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 31. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2020 VS 2026 (%)
FIGURE 32. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2020 VS 2026 (USD MILLION)
FIGURE 33. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2026
FIGURE 34. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY AIDS, 2018-2026 (USD MILLION)
FIGURE 35. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY AIDS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 36. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HEMOPHILIA, 2018-2026 (USD MILLION)
FIGURE 37. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HEMOPHILIA, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 38. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2026 (USD MILLION)
FIGURE 39. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MULTIPLE SCLEROSIS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 40. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONCOLOGY, 2018-2026 (USD MILLION)
FIGURE 41. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONCOLOGY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 42. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2026 (USD MILLION)
FIGURE 43. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 44. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (%)
FIGURE 45. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (USD MILLION)
FIGURE 46. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2026
FIGURE 47. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, 2018-2026 (USD MILLION)
FIGURE 48. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 49. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDEPENDENT PHARMACIES, 2018-2026 (USD MILLION)
FIGURE 50. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDEPENDENT PHARMACIES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 51. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY LARGE CHAIN PHARMACIES, 2018-2026 (USD MILLION)
FIGURE 52. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY LARGE CHAIN PHARMACIES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 53. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE STORES, 2018-2026 (USD MILLION)
FIGURE 54. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE STORES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 55. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY PHARMACIES, 2018-2026 (USD MILLION)
FIGURE 56. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY PHARMACIES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 57. CALIFORNIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 58. FLORIDA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 59. ILLINOIS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 60. NEW YORK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 61. OHIO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 62. PENNSYLVANIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 63. TEXAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 64. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET: FPNV POSITIONING MATRIX
FIGURE 65. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 66. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET, BY TYPE

List of Tables
TABLE 1. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2026 (USD MILLION)
TABLE 5. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY CLINIC/ASCS, BY STATE, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME HEALTH, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INPATIENT, BY STATE, 2018-2026 (USD MILLION)
TABLE 8. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MAIL DELIVERY, BY STATE, 2018-2026 (USD MILLION)
TABLE 9. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY OUTPATIENT, BY STATE, 2018-2026 (USD MILLION)
TABLE 10. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RETAIL, BY STATE, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 12. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY FULL LINE WHOLESALERS, BY STATE, 2018-2026 (USD MILLION)
TABLE 13. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY DISTRIBUTORS, BY STATE, 2018-2026 (USD MILLION)
TABLE 14. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2018-2026 (USD MILLION)
TABLE 15. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY AIDS, BY STATE, 2018-2026 (USD MILLION)
TABLE 16. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HEMOPHILIA, BY STATE, 2018-2026 (USD MILLION)
TABLE 17. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MULTIPLE SCLEROSIS, BY STATE, 2018-2026 (USD MILLION)
TABLE 18. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONCOLOGY, BY STATE, 2018-2026 (USD MILLION)
TABLE 19. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY STATE, 2018-2026 (USD MILLION)
TABLE 20. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 21. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY STATE, 2018-2026 (USD MILLION)
TABLE 22. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDEPENDENT PHARMACIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 23. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY LARGE CHAIN PHARMACIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 24. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE STORES, BY STATE, 2018-2026 (USD MILLION)
TABLE 25. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY PHARMACIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 26. CALIFORNIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 27. FLORIDA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 28. ILLINOIS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 29. NEW YORK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 30. OHIO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 31. PENNSYLVANIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 32. TEXAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 33. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET: SCORES
TABLE 34. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET: BUSINESS STRATEGY
TABLE 35. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET: PRODUCT SATISFACTION
TABLE 36. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET: RANKING
TABLE 37. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 38. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET: MERGER & ACQUISITION
TABLE 39. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 40. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 41. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET: INVESTMENT & FUNDING
TABLE 42. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 43. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Anda, Inc.
  • Avella Specialty Pharmacy
  • Biologics, Inc.
  • CuraScript, Inc.
  • CVS Health Corporation
  • Diplomat Pharmacy, Inc.
  • Express Scripts Holding Company
  • Greenhill & Co., Inc.
  • Pfizer Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll